Seminars

• 2010-04-09 Professor Tom Koch: DISEASE PROFILING: MAPPING DISEASE STATISTICS, Co-sponsored by York University's Institute for Social Research and Faculty of Health

• 2010-03-31 Dr. Sandra Gardner: Analyzing data from the Ontario HIV Treatment Network Cohort Study: Is viral hepatitis testing deficient in HIV seropositive patients?

• 2010-01-20 Grey Pond: Dynamic Allocation Methods: Why the Controversy?

• 2009-11-25 Heather Krause: Semiparametric Mixed Models: A Best of Both World Approach

• 2009-03-03 Chun-Po Steve Fan: Spatial distribution of the risk of newly diagnosed lupus cases in the Greater Toronto area: an application of small area estimation for spatially aggregated data with time-varying boundaries

• 2008-11-04 John Amrhein: A Case Study in Time-to-Event Analysis with Clustered Observations

• 2008-10-15 Manny Papadimitropoulos: Global Health Economics - Methods & Issues - an international perspective

• 2008-03-31 William Evans: The Cost of Lung Cancer in Canada

• 2007-04-18 Peter Austin: Astrological signs and health outcomes: Lessons for clinical
  and epidemiological research

• 2007-10-30 May Tang and John Sparkes: Potency Assay of Vaccines for Human Use

• 2006-11-02 Andy Willan: Statistical Analysis of Cost-Effectiveness Data

• 2006-09-28 Peter Song: Handling Missing Data in Linear Mixed-Effects Models

• 2006-06-20 Jenny Huang: Analysis of Long-Term Adverse Events with Competing Risk(s) in a Clinical Trial Setting

• 2006-04-05 Lise Le: A comparison of methods for the analysis of pre-post data in RCT's

• 2005-06-29 Gerarda Darlington: Analysis of Pretest-Posttest data in Cluster Randomization Trials

• 2005-04-12 Dr. Therese Stukel: Confounders in Observational Studies

• 2004-10-25 Melania Pintile: Competing Risk

• 2004-06-23 Johan Harmsen: What is a sigma and why do I need 6 of them?

• 2004-03-23 Georges Monette:Longitudinal Models for Clinical Data: some case studies

• 2004-01-14 Fernando Camacho, Ivan Hon and Swetlana Ljubicic: The Statistical Society of Canada Accreditation process and mentoring

• 2003-10-23 Andreas Laupacis: Drug reimbursement in Ontario: How are decisions currently made, and how can they be made better?

• 2003-03-31 Andreas Laupacis: Making effective drugs available without bankrupting the health care system

• 2003-02-11 Dr. Neil Klar: Cluster Randomization Trials in Health Research: An Introduction to Design and Analysis

• 2002-11-14 Judy-Anne Chapman: The Use of Location-Scale (log-normal) Survival Analysis with Breast Cancer Data

• 2002-10-08 Dr. Lehana Thaban: Incorporating Prior Information in the Analysis of Clinical Data: An Introduction to Bayesian Thinking in Health Research

• 2002-03-20 Raymond Lam: Molecule Selection and Mining Nuggets from High Throughput Screening Data

• 2001-10-24 Richard Cook: Incomplete Data in Longitudinal Trial

•